BioCentury
ARTICLE | Clinical News

Introgen preclinical data

June 13, 2005 7:00 AM UTC

In a hamster model of cancer, INGN 007 significantly inhibited tumor growth and metastasis. INGN licensed the replicating adenovirus vector overexpressing ADP from VirRx Inc. (St. Louis, Mo.). Data we...